These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 2926985

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P.
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
    Hancock KC, Freedman RS, Edwards CL, Rutledge FN.
    Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
    Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S, Kudo R, Japanese Gynecologic Oncology Group.
    Gynecol Oncol; 2008 Jan; 108(1):226-33. PubMed ID: 17996926
    [Abstract] [Full Text] [Related]

  • 9. Doxorubicin and cyclophosphamide chemotherapy for disseminated endometrial cancer.
    Seski JC, Edwards CL, Gershenson DM, Copeland LJ.
    Obstet Gynecol; 1981 Jul; 58(1):88-91. PubMed ID: 7195533
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Results of combination chemotherapy in advanced urothelial cancer].
    Komatsubara S, Watanabe M, Kitamura Y, Sakata Y.
    Hinyokika Kiyo; 1988 Oct; 34(10):1697-702. PubMed ID: 3245518
    [Abstract] [Full Text] [Related]

  • 14. [A case of advanced gastric cancer responding to an FAP (5-FU, ADM, platinum compounds) combined chemotherapy].
    Miyahara E, Takiyama W, Sakamoto N, Azuma T, Ohashi R, Kirihara Y, Doihara H, Yokoyama N, Tanada M, Soga H.
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):643-6. PubMed ID: 8470923
    [Abstract] [Full Text] [Related]

  • 15. [Combination chemotherapy with UFT, etoposide, CDDP, adriamycin (FEPA) in advanced gastric cancer].
    Hayakawa M, Morise K, Sakai T, Thin K, Ando T, Kokubu K, Akatsuka Y, Sato Y, Tahara H, Kuwahara Y.
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3393-8. PubMed ID: 2508565
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin].
    Kitayama S, Iwahashi M, Iwahashi M, Yamoto M, Nakano R.
    Gan To Kagaku Ryoho; 1989 May; 16(5):2099-101. PubMed ID: 2730095
    [Abstract] [Full Text] [Related]

  • 20. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
    Arcangeli G, Righini R, Nervi C, Guerra A, Tirindelli D, Hopkins H, Looney W.
    Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.